[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Immune System and Cancer
[If this is a double post, please forgive. . . .my ISP
seems to have a problem posting to RadSafe from time to
time.)
===================
Folks,
It seems to me that the whole basis of cancer is that it
is an uncontrolled growth of cells. Thus, almost by
definition, the immune system cannot control the spread
of the tumor cells -- that's why it's cancer.
Cancer, however, is a multistaged disease. Cells go
through several stages of "preparatory transformations"
before becoming cancerous, assuming they ever do. My
understanding is that in these stages, many of these
cells are identifiable by the immune system, and that the
immune system is involved in the control of these
permutated cells. Thus, if the immune system is
stimulated, it can be made more effective in terminating
or otherwise thwarting these modified cells lines before
they become cancerous.
I have done a fair amount of reading in this area (I am
not a professional researcher), and it appears to me that
the immune stimulation effect is supportable (I am
particularly intrigued by a study on murine AIDS and by
the work in Japan using radiation to stimulate the
immune system). Most of the literature suggests a direct
effect upon the cells, but (in vivo; at relatively high
dose rates, but moderate doses), I think there is strong
evidence supporting a neurological stimulation effect,
with resulting cytokinetic activity that amplifies these
direct effects.
This can cut both ways; one can get a radioprotective
effect from such cytokinetic activity, but could also
trigger a sickness behavior due to a disruption in normal
cytokine levels.
Jim Barnes, CHP
james.g.barnes@att.net
************************************************************************
You are currently subscribed to the Radsafe mailing list. To unsubscribe,
send an e-mail to Majordomo@list.vanderbilt.edu Put the text "unsubscribe
radsafe" (no quote marks) in the body of the e-mail, with no subject line.